RxDoctor Payments Data

Pouya Mohajer, MD

Pain Medicine · Las Vegas, NVNPI 1225030919

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Kowa Pharmaceuticals America, Inc. at 40.3% of the total. Reporting peaked in 2023 at $7,533 and has fallen 81.5% since, to $1,396 in 2025. Among pain medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,978in general payments, 2019–2025

Across 216 payments — averaging $78.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$7K
  • Boston Scientific$4K
  • Cook Medical LLC$2K
  • Medtronic$1K
  • Abbott$1K
  • Biotronik NRO, Inc.$927
  • plus $2K from 13 others

What the payments were for

  • Speaking & faculty fees$6,50038%
  • Travel & lodging$7374%
  • Food & beverage$9,29555%
  • Education$4463%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,978 in reported general payments places this provider in the 90th percentile of 101 pain medicine providers in Nevada.

See all pain medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$442,495
Medicare patients
415
Services billed
13,639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen111$36,313
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen199$4,283
Lidocaine23$3,237
Gabapentin140$1,960
Oxycodone Hcl76$1,344
Fentanyl12$982
Morphine Sulfate ErMorphine Sulfate37$980
Nortriptyline Hcl81$907
Carisoprodol45$770
Pregabalin40$607
Baclofen56$510
Tizanidine Hcl44$496
Cyclobenzaprine Hcl70$454
Methocarbamol20$426
Morphine Sulfate12$356

Paid to pharmacies, not to this prescriber.

Other pain medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →